Skip to main content
Main Corporate Nav
About Us
Overview
Leadership
Board of Directors
Partnering
Our History
Pipeline
Overview
AL Amyloidosis & Birtamimab
Parkinson's Disease & Prasinezumab
ATTR Amyloidosis & PRX004
Alzheimer's Disease
Pioneering Neuroscience
Publications
Clinical Trials
Overview
Birtamimab Phase 3 Study
Prasinezumab Phase 2 Study
PRX004 Phase 1 Study
PRX005 Phase 1 Study
PRX012 Phase 1 Study
Expanded Access Policy
Investors
Overview
Press Releases
Events & Presentations
Financials & Filings
Corporate Governance
Stock information
Analyst Coverage
Careers
Overview
Our Values
Compensation & Benefits
Opportunities
Public House
Contact Us
Events & Presentations
Overview
Press Releases
Events & Presentations
Financials & Filings
SEC Filings
Quarterly Results
Key Ratios
Irish Statutory Financial Statements
Corporate Governance
Committee Composition
Stock Information
Analyst Coverage
Upcoming Events
Date
Event Details
PRESENTATIONS
Date
DOCUMENTS
ARCHIVED EVENTS
Date
EVENT DETAILS